Internal Medicine, Nephrology · Florence, AL
NPI
1033117817
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
422 E Dr Hicks Blvd
Florence, AL, 35630
Phone (256) 766-1401
Groups this clinician bills Medicare through
Medicare paid, 2024
$307K
11,417 services
Medicare patients, 2024
593
Average age 75
Drug cost, 2024
$778K
2,769 prescriptions
Company payments, 2025
$866
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajesh Boorgu was code 99232 (hospital e&m - subsequent), 1,397 times for 315 patients. In total Rajesh Boorgu billed 11,417 services in 51 codes, and Medicare paid $307K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,397 | 315 | $59.17 | $83K |
| 36415 Venipuncture Blood Collection | Office | 390 | 159 | $8.65 | $3,374 |
| 99233 Hospital E&M - Subsequent | Facility | 386 | 133 | $93.17 | $36K |
| 85025 Blood Count | Office | 383 | 161 | $7.61 | $2,914 |
| 80053 Clinical Chemistry | Office | 358 | 161 | $10.31 | $3,691 |
| 84550 Clinical Chemistry | Office | 354 | 160 | $4.43 | $1,568 |
| 84100 Clinical Chemistry | Office | 354 | 160 | $4.65 | $1,646 |
| 83735 Clinical Chemistry | Office | 338 | 151 | $6.56 | $2,217 |
| 90970 ESRD Related Services (not dialysis) | Office | 324 | 26 | $6.98 | $2,262 |
| 84156 Clinical Chemistry | Office | 309 | 155 | $3.60 | $1,112 |
| 82570 Clinical Chemistry | Office | 309 | 155 | $5.08 | $1,569 |
| 99214 Office E&M - Established | Office | 290 | 155 | $70.76 | $21K |
| 99223 Hospital E&M - Initial | Facility | 255 | 224 | $133.45 | $34K |
| 80061 Clinical Chemistry | Office | 234 | 125 | $13.03 | $3,048 |
| 82550 Clinical Chemistry | Office | 233 | 124 | $6.37 | $1,484 |
By year: 2022 $395K for 9,052 services; 2023 $382K for 11,230 services; 2024 $307K for 11,417 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 390 | 159 | $8.65 | $3,374 |
| 85025 Blood Count | 383 | 161 | $7.61 | $2,914 |
| 80053 Clinical Chemistry | 358 | 161 | $10.31 | $3,691 |
| 84550 Clinical Chemistry | 354 | 160 | $4.43 | $1,568 |
| 84100 Clinical Chemistry | 354 | 160 | $4.65 | $1,646 |
| 83735 Clinical Chemistry | 338 | 151 | $6.56 | $2,217 |
| 84156 Clinical Chemistry | 309 | 155 | $3.60 | $1,112 |
| 82570 Clinical Chemistry | 309 | 155 | $5.08 | $1,569 |
| 80061 Clinical Chemistry | 234 | 125 | $13.03 | $3,048 |
| 82550 Clinical Chemistry | 233 | 124 | $6.37 | $1,484 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajesh Boorgu prescribed most often to Medicare patients was Losartan Potassium, with 174 prescriptions and refills. In total Rajesh Boorgu wrote 2,769 Medicare prescriptions that cost $778K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 174 | 468 | 68 | $1,673 |
| Chlorthalidone Generic | 172 | 468 | 62 | $2,113 |
| Furosemide Generic | 146 | 334 | 54 | $760 |
| Amlodipine Besylate Generic | 130 | 288 | 56 | $510 |
| Allopurinol Generic | 116 | 258 | 40 | $725 |
| Lisinopril Generic | 98 | 254 | 31 | $636 |
| Xphozah Tenapanor Hcl | 78 | 91 | 25 | $263K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 61 | 30 | $1,008 |
| Levothyroxine Sodium Generic | 60 | 138 | 27 | $736 |
| Atorvastatin Calcium Generic | 55 | 91 | 35 | $512 |
| Simvastatin Generic | 51 | 141 | 19 | $239 |
| Carvedilol Generic | 51 | 109 | 19 | $287 |
| Potassium Chloride Generic | 50 | 100 | 25 | $2,467 |
| Calcium Acetate Generic | 48 | 82 | 23 | $5,078 |
| Pantoprazole Sodium Generic | 45 | 79 | 21 | $466 |
Brand drugs: - claims; generic drugs: 2,375 claims; opioid claims: 102.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajesh Boorgu $866 ($866 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $249.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $249 |
| Akebia Therapeutics Inc AKBA | 4 | $171 |
| Amgen Inc. AMGN | 6 | $106 |
| Novo Nordisk Inc NVO | 4 | $67.61 |
| Ardelyx, Inc. ARDX | 3 | $55.24 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $54.79 |
| Vifor Pharma, Inc. | 2 | $46.75 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $38.8 |
| OPKO Pharmaceuticals, LLC | 2 | $31.37 |
| Vantive US Healthcare LLC | 1 | $25.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.